Canine genomics co. scores $75M in fundingJuly 29, 2021A canine genomics and biotechnology company hoping to increase the lifespan of dogs by three years within the next decade has raised $75 million in Series B funding.
SPONSORED CONTENTAre Your Patients Fully Protected?Fleas, ticks, heartworms, and intestinal parasites—dogs face multiple threats. See how a multi-parasite approach can offer your patients a broad range of protection. + Learn More
